MA (EU) number 
(Invented) 
Strength 
Pharmaceutical 
Route of 
Immediate 
Content 
Pack size 
name 
form 
administration 
Packaging 
(concentration) 
EU/1/96/006/008 
NovoSeven 
EU/1/96/006/009 
NovoSeven 
EU/1/96/006/010 
NovoSeven 
EU/1/96/006/011 
NovoSeven 
1 mg (50 
KIU) 
Powder and 
solvent for solution 
for injection 
Intravenous use 
2 mg (100 
KIU) 
Powder and 
solvent for solution 
for injection 
5 mg (250 
KIU) 
Powder and 
solvent for solution 
for injection 
8 mg (400 
KIU) 
Powder and 
solvent for solution 
for injection 
Intravenous use 
Intravenous use 
Intravenous use 
powder: vial 
(glass); solvent: 
syringe (glass) 
powder: vial 
(glass); solvent: 
syringe (glass) 
powder: vial 
(glass); solvent: 
syringe (glass) 
powder: vial 
(glass); solvent: 
syringe (glass) 
powder: 1 mg (50 
KIU); (50 
KIU/ml); solv.: 1 
ml 
powder: 2 mg 
(100 KIU); (50 
KIU/ml); solv.: 2 
ml 
powder: 5 mg 
(250 KIU); (50 
KIU/ml) solv.: 5 
ml 
powder: 8 mg 
(400 KIU); (50 
KIU/ml) solv.: 8 
ml 
1 vial + 1 syringe 
+ 1 vial adapter 
1 vial + 1 syringe 
+ 1 vial adapter 
1 vial + 1 syringe 
+ 1 vial adapter 
1 vial + 1 syringe 
+ 1 vial adapter 
1/ 1 
 
